Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 586
Selected: 0
NCT IDTitle
NCT07307443A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.
NCT07773818Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study
NCT03839550Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection
NCT05444491Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
NCT04370925Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
NCT0627718068Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NCT07321262Machine Learning to Predict Postoperative Pneumonia in Brain Tumor Patients
NCT07132242SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer
NCT05443672Multi-center Study of Deep Learning AI in Breast Mass
NCT06958627The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study
NCT03713372Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
NCT06073730Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients
NCT07858630Radiotherapy Target Volume Delineation in Locally Advanced Esophageal Cancer in the Immunotherapy Era
NCT01238562Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients
NCT04506242Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer
NCT07043894Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
NCT07454941Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
NCT06410651Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
NCT06342336HS-IT101 Injection in the Treatment of Advanced Solid Tumors
NCT07690332A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α(FRα)
NCT05009017Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients
NCT06170697Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
NCT05894889Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC
NCT02395705Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
NCT04498793Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer
NCT07186868QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer
NCT02503150Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer
NCT07014202Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
NCT04664439Follow-up With CT-FFR in CHD Patients After DCB
NCT04807673Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
NCT05888402Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC
NCT06149533Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
NCT07187193Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
NCT07743749An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors
NCT02540850CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population
NCT06959732Zanubrutinib Combined With G-CVP in Previously Untreated FL
NCT06958614Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC
NCT07791615A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma
NCT04821765Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
NCT06034964Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
NCT07435701Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
NCT07626528Study of Wenyang Tongbi Formula in the Treatment of Chemotherapy-Induced Polyneuropathy
NCT06839560Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain Metastasis
NCT06048146A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis
NCT06793813Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07351266Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors
NCT03731754"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection
NCT06189183Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
NCT06490380HRD Status Reference Standard Based on WGS
NCT05542680Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal Cancer